Cargando…
Metabolite identification, tissue distribution, excretion and preclinical pharmacokinetic studies of ET-26-HCl, a new analogue of etomidate
ET-26-HCl, a novel anaesthetic agent with promising pharmacological properties, lacks extensive studies on pharmacokinetics and disposition in vitro and in vivo. In this study, we investigated the metabolic stability, metabolite production and plasma protein binding (PPB) of ET-26-HCl along with its...
Autores principales: | Yu, Lu, Chen, Xu, Zhang, Wen Sheng, Zheng, Liang, Xu, Wen Wen, Xu, Ming Yu, Jiang, Xue Hua, Wang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062083/ https://www.ncbi.nlm.nih.gov/pubmed/32257329 http://dx.doi.org/10.1098/rsos.191666 |
Ejemplares similares
-
The etomidate analog ET-26 HCl retains superior myocardial performance: Comparisons with etomidate in vivo and in vitro
por: Liu, Xingxing, et al.
Publicado: (2018) -
ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats
por: Wang, Bin, et al.
Publicado: (2017) -
Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats
por: Jiang, Junli, et al.
Publicado: (2017) -
Pharmacokinetics, bioavailability, tissue distribution and excretion of tangeretin in rat
por: Hung, Wei-Lun, et al.
Publicado: (2017) -
E161111 is an ultra-short-acting etomidate analogue with stable haemodynamics that elicits only slight adrenocortical suppression in rats
por: Wang, Bin, et al.
Publicado: (2022)